Skip to main content
. 2021 Apr 19;12:641378. doi: 10.3389/fimmu.2021.641378

Table 5.

The performance of various methods for differentiating ATB from LTBI in participants with positive T-SPOT results.

Variables Cutoff value AUC (95% CI) Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) PLR (95% CI) NLR (95% CI) Accuracy
ESAT-6/PHA ratio 0.13 0.815 (0.727-0.903) 48.72% (33.86%-63.80%) 92.19% (82.98%-96.62%) 79.17% (59.53%-90.76%) 74.68% (64.11%-82.97%) 6.24 (2.53-15.35) 0.56 (0.41-0.76) 75.73%
CFP-10/PHA ratio 0.115 0.899 (0.837-0.961) 66.67% (50.98%-79.37%) 93.75% (85.00%-97.54%) 86.67% (70.32%-94.69%) 82.19% (71.88%-89.29%) 10.67 (4.03-28.26) 0.36 (0.23-0.56) 83.50%
TBAg/PHA ratio 0.16 0.889 (0.827-0.952) 64.10% (48.42%-77.26%) 90.63% (81.02%-95.63%) 80.65% (63.72%-90.81%) 80.56% (69.97%-88.05%) 6.84 (3.08-15.17) 0.40 (0.26-0.61) 80.58%
Diagnostic model 0.57 0.936 (0.890-0.981) 82.05% (67.33%-91.02%) 90.63% (81.02%-95.63%) 84.21% (69.58%-92.56%) 89.23% (79.40%-94.69%) 8.75 (4.03-19.01) 0.20 (0.10-0.39) 87.38%

ATB, active tuberculosis; LTBI, latent tuberculosis infection; ESAT-6, early secreted antigenic target 6; CFP-10, culture filtrate protein 10; AUC, area under the curve; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio; CI, confidence interval.